Cargando…
iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System
[Image: see text] For oral drugs, the formulator and discovery chemist have a tool available to them that can be used to navigate the risks associated with the selection and development of immediate release oral drugs and drug products. This tool is the biopharmaceutics classification system (giBCS)...
Autores principales: | Hastedt, Jayne E., Bäckman, Per, Cabal, Antonio, Clark, Andy, Ehrhardt, Carsten, Forbes, Ben, Hickey, Anthony J., Hochhaus, Guenther, Jiang, Wenlei, Kassinos, Stavros, Kuehl, Philip J., Prime, David, Son, Yoen-Ju, Teague, Simon, Tehler, Ulrika, Wylie, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257742/ https://www.ncbi.nlm.nih.gov/pubmed/35576168 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00113 |
Ejemplares similares
-
iBCS: 2. Mechanistic Modeling of Pulmonary Availability
of Inhaled Drugs versus Critical Product Attributes
por: Bäckman, Per, et al.
Publicado: (2022) -
An Overview on Dietary Polyphenols and Their Biopharmaceutical Classification System (BCS)
por: Truzzi, Francesca, et al.
Publicado: (2021) -
Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development
por: Wolk, Omri, et al.
Publicado: (2014) -
Integrating In Vitro Biopharmaceutics into Physiologically Based Biopharmaceutic Model (PBBM) to Predict Food Effect of BCS IV Zwitterionic Drug (GSK3640254)
por: Stamatopoulos, Konstantinos, et al.
Publicado: (2023) -
Select agent program impact on the IBC
por: Adamovicz, Jeffery
Publicado: (2016)